Search

everythinglearnresearchcommunity

for

Search:↓

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Finasteride may help reduce COVID-19 infection by altering a key gene.

TMPRSS2 affects COVID-19 severity and treatment options.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Vitamin D may help prevent or reduce hair loss after COVID-19.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Possible link between COVID-19 and hair loss; more research needed.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

COVID-19 may cause hair loss by affecting hair follicles.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Low testosterone may indicate severe COVID-19 in men.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

COVID-19 may harm male fertility and damage the reproductive system.

Testosterone may both worsen and protect against COVID-19 effects in men.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Men have more severe COVID-19 outcomes than women.